Evaxion A (EVAX) Operating Income (2020 - 2026)
Evaxion A (EVAX) posted Operating Income of -$3.8 million for Q1 2026, up 5.75% on a QoQ basis from -$4.1 million in Q4 2025, and up 1.27% year-over-year from -$3.8 million in Q1 2025.
Evaxion A (EVAX) Operating Income (2020 - 2026) Analysis & Trends
Evaxion A's Operating Income history runs 7 years deep, the most recent figure standing at -$3.8 million for Q1 2026.
- Quarterly Operating Income rose 1.27% year-over-year to -$3.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$9.2 million (up 35.31% YoY) and the FY2025 annual result came in at -$9.2 million, up 37.32% from the prior year.
- Operating Income was -$3.8 million for Q1 2026 at Evaxion A, up from -$4.1 million in the prior quarter.
- Across five years, Operating Income topped out at $3.0 million in Q3 2025 and bottomed at -$6.5 million in Q4 2022.
- A 5-year average of -$4.4 million and a median of -$4.4 million in 2024 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2022 — Operating Income declined 23.65% — and 2025, when it surged 274.58%.
- Evaxion A's Operating Income stood at -$6.5 million in 2022, then surged by 33.12% to -$4.4 million in 2023, then increased by 7.79% to -$4.0 million in 2024, then declined by 0.7% to -$4.1 million in 2025, then grew by 5.75% to -$3.8 million in 2026.
- Business Quant data shows EVAX's Operating Income at -$3.8 million in Q1 2026, -$4.1 million in Q4 2025, and $3.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Evaxion A | 25.44 Mn | 25.44 Mn | - | -3.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.82 Mn |
| Dec 31, 2025 | -4.05 Mn |
| Sep 30, 2025 | 3.02 Mn |
| Jun 30, 2025 | -4.34 Mn |
| Mar 31, 2025 | -3.87 Mn |
| Dec 31, 2024 | -4.02 Mn |
| Sep 30, 2024 | -1.73 Mn |
| Jun 30, 2024 | -4.58 Mn |
| Mar 31, 2024 | -4.40 Mn |
| Dec 31, 2023 | -4.36 Mn |
| Sep 30, 2023 | -5.76 Mn |
| Jun 30, 2023 | -5.68 Mn |
| Mar 31, 2023 | -6.53 Mn |
| Dec 31, 2022 | -6.53 Mn |
| Sep 30, 2022 | -6.08 Mn |
| Jun 30, 2022 | -6.26 Mn |
| Mar 31, 2022 | -6.40 Mn |
| Dec 31, 2021 | -7.72 Mn |
| Sep 30, 2021 | -18.11 Mn |
| Jun 30, 2021 | -12.20 Mn |